Americans Are Dangerously Dependent on Foreign-made Generic Drugs. Tariffs Can Fix That.
Tariffs on pharmaceutical companies isn’t just good economic policy — it benefits national security and public health.
Imports Show Near-Zero Growth Month Over Month As Tariff Reset Begins
Imports did not vanish, but their growth rate was flat at zero percent in February compared to January after nearly two months of importers rushing in orders ahead of tariffs. February goods and services imports were $401 billion, a statistically insignificant change from January, the Bureau of Economic Analysis said.
What Members of the House Ways and Means Committee Are Saying About Tariffs
Members of the House Ways and Means Committee gave U.S. Trade Representative Jamieson Greer a piece of their mind on Wednesday during a four-and-a-half-hour hearing—double the time he spent with the Senate Finance Committee the day before.
Is China Gaining Ground in the New Space Race?
Is China a peer competitor in the space race? On some fronts, the answer is yes. In others, the concern is that China is moving up the value chain so quickly that its companies may soon out-price American firms across the developing world.
USTR Jamieson Greer Tells Senate: Trump Tariffs Will Stay as U.S. Shifts to Producer Economy
The Trump administration is not backing down from its America First trade agenda, and Congress has granted the executive branch the authority to use emergency powers to impose tariffs in support of that agenda, U.S. Trade Representative Jamieson Greer told the Senate Finance Committee in a hearing on Tuesday.
America’s Generic Drug Crisis Demands Investment, Not Dependence
The United States is amid a dangerous drug shortage that endangers patients, undermines our health care system and exposes a deep vulnerability to national security. America’s overwhelming reliance on foreign manufacturers for generic drugs is at the center of it.
Why the U.S. Needs President Trump’s Tariffs
On April 2, President Donald Trump took bold and historic action to defend American industry with the announcement of sweeping new tariffs aimed at countering unfair foreign trade practices and reigniting U.S. manufacturing. Dubbed “Liberation Day”, this policy marks the first major step in a new era of economic revitalization—one where the United States refuses to accept the systematic dismantling of its industrial base and begins to chart a path back to true production-led prosperity.
Kenneth Rapoza: Happy Liberation Day, America
Break out the Grizzly cooler and fire up the Broilmaster—it’s Liberation Day. In President Trump’s words, April 2 marks the end of the US of A being “ripped off by virtually every country in the world.”
Wall Street Doesn’t Reflect the Real Economy
The stock market is not the economy, and it certainly isn’t a proxy for the health of U.S. manufacturing or working-class prosperity.
CPA Endorses Enhanced Enforcement Actions Following Concerns Raised in USTR’s 2025 National Trade Estimate Report
The NTE report specifically identifies significant barriers and illicit trade practices, particularly involving China, impacting the solar, automotive, and steel industries, underscoring the urgent need for robust U.S. enforcement to address transshipment and tariff evasion.